+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Analysis of Barretts esophagus causes and risk factors for dysplasia and drug treatment to reverse dysplasia in Barretts esophagus



Analysis of Barretts esophagus causes and risk factors for dysplasia and drug treatment to reverse dysplasia in Barretts esophagus



American Journal of Gastroenterology 98(9 Suppl.): S27




(PDF emailed within 0-6 h: $19.90)

Accession: 034397923

Download citation: RISBibTeXText

DOI: 10.1016/s0002-9270(03)00847-5


Related references

Expression of trefoil factors in Barretts esophagus, dysplasia and adenocarcinoma arising in Barretts. Laboratory Investigation 82(1): 124A-125A, 2002

Risk factors for dysplasia in patients with Barretts esophagus Results from a multicenter consortium. Gastroenterology 116(4 PART 2): A175, 1999

Risk factors for developing dysplasia or adenocarcinoma in Barretts esophagus with implications for endoscopic surveillance. Gastroenterology. 106(4 Suppl.): A45, 1994

Incidence of high grade dysplasia/adenocarcinoma in Barretts esophagus A propective study in a low risk country for adenocarcinoma of the esophagus. Gastroenterology 118(4 Suppl 2 Part 1): A38, 2000

Cost effectiveness analysis of photodynamic therapy for treatment of high grade dysplasia in barretts esophagus. Digestive Disease Week Abstracts & Itinerary Planner : Abstract No 319, 2003

KTP-laser treatment of dysplasia in Barretts esophagus. Gastroenterology 112(4 SUPPL ): A570, 1997

Sucrase-isomaltase expression in gastric dysplasia and in dysplasia associated with Barretts esophagus. Laboratory Investigation 68(1): 49A, 1993

Barretts esophagus Elimination of dysplasia and reduction of Barretts mucosa following photodynamic therapy and long-term omeprazole therapy. Gastroenterology 106(4 SUPPL ): A424, 1994

Dysplasia in Barretts esophagus Morphologic and molecular analysis. Laboratory Investigation 81(1): 93A, 2001

Dysplasia in Barretts Esophagus: Diagnosis, Surveillance and Treatment. Digestive Diseases 14(4): 213-227, 2008

Quantitative mRNA expression analysis of multiple genes distinguish between Barretts-esophagus and Barretts-associated adenocarcinoma of the esophagus. Proceedings of the American Association for Cancer Research Annual Meeting 43: 464-465, 2002

Acid suppression does not decrease the risk of low grade dysplasia in Barretts esophagus. Gastroenterology 116(4 PART 2): A335, 1999

T1932 Basal Crypt Dysplasia Is Highly Associated with Conventional Dysplasia in Barretts Esophagus: A Seattle Cohort Study of 101 Patients. Gastroenterology 136(5): A-603, 2009

Barretts esophagus How to improve diagnosis and treatment diagnostic tools of dysplasia. Acta Endoscopica 29(5): 583, 1999

Fluorescence in situ hybridization of endoscopic brush cytology from barretts esophagus detects genetic changes in high grade dysplasia and adenocarcinoma not seen in patients without dysplasia. Digestive Disease Week Abstracts & Itinerary Planner : Abstract No 576, 2003